{"id":"W2134683286","doi":"10.1111/j.1538-7836.2012.04693.x","title":"A randomized phase II trial of apixaban for the prevention of thromboembolism in patients with metastatic cancer","year":2012,"lang":"en","type":"article","venue":"Journal of Thrombosis and Haemostasis","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":190,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University; Montreal General Hospital; McMaster University; Ontario Clinical Oncology Group","funders":"","keywords":"Apixaban; Medicine; Internal medicine; Placebo; Chemotherapy; Cancer; Adverse effect; Population; Randomized controlled trial; Surgery; Warfarin; Atrial fibrillation; Rivaroxaban","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001729121,0.0001686423,0.001788094,0.0002098053,0.00007792161,0.00001036074,0.0001004925,0.00004470303,0.00009293527],"category_scores_gemma":[0.0001733206,0.00008989464,0.0003645926,0.0001948852,0.0001699457,0.0002216228,0.0000448087,0.0001188207,1.130912e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004312737,"about_ca_system_score_gemma":0.00008687437,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001145964,"about_ca_topic_score_gemma":0.0000195437,"domain_scores_codex":[0.998093,0.000132907,0.00099025,0.0001080495,0.0004458436,0.0002299413],"domain_scores_gemma":[0.9978569,0.0003496165,0.001194307,0.0001801138,0.0003209198,0.00009811943],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8313586,0.03758015,0.01075049,0.0013541,0.01224132,0.000001215079,0.009315669,0.00007400302,0.0004196087,0.001854899,0.004794803,0.09025519],"study_design_scores_gemma":[0.9197739,0.007152493,0.06103603,0.0007839902,0.007800967,0.000002025264,0.0006417776,0.00004471466,0.00173088,0.0002840877,0.0006193205,0.0001298307],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9935195,0.002050064,0.0004255431,0.001022801,0.000300136,0.002593799,0.00003407078,0.000002403639,0.00005163267],"genre_scores_gemma":[0.9947813,0.003416438,0.001428062,0.000114023,0.0001199811,0.0001017883,0.000005856601,0.00001999382,0.00001261351],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09012536,"threshold_uncertainty_score":0.3665797,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06639380112779261,"score_gpt":0.37552157031707,"score_spread":0.3091277691892773,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}